anti-Sialyl-di-Lewis CAR T-cell therapy (Scancell/Nottingham University)

N/A

Report date: 2025/06/11 10:39:48

Base Information

Drug Nameanti-Sialyl-di-Lewis CAR T-cell therapy (Scancell/Nottingham University)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionImmunostimulantsT lymphocytes stimulants

TargetsUpdating

Therapy Area/IndicationsGastrointestinal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Nottingham

China Registration ClassN/A

Develop Information

Active CompaniesScancell Ltd University Of Nottingham

Inactive CompaniesN/A

Active IndicationsGastrointestinal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A